Document Detail


Variation in recognition of recurrent colonic cancer by different CEA assays.
MedLine Citation:
PMID:  3803120     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Forty-six patients were followed with serial CEA determinations by two CEA assays after curative resection of a primary or recurrent colonic cancer. Thirteen have had a histologically proven recurrence, of which only six (46 percent) were predicted by both assays, while seven (54 percent) were predicted by one assay only. The assays appear complementary in indicating tumor recurrence, and preliminary findings suggest that it may be beneficial to follow patients with more than one CEA assay after resection of a primary or recurrent colonic cancer.
Authors:
P J O'Dwyer; C Mojzisik; D P McCabe; B J Sickle-Santanello; W B Farrar; E W Martin
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Diseases of the colon and rectum     Volume:  30     ISSN:  0012-3706     ISO Abbreviation:  Dis. Colon Rectum     Publication Date:  1987 Feb 
Date Detail:
Created Date:  1987-03-16     Completed Date:  1987-03-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372764     Medline TA:  Dis Colon Rectum     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  133-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Carcinoembryonic Antigen / analysis*
Colonic Neoplasms / diagnosis*
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Recurrence, Local / diagnosis*
Postoperative Care
Sigmoid Neoplasms / diagnosis*
Chemical
Reg. No./Substance:
0/Carcinoembryonic Antigen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Presacral hematomas. Diagnosis and treatment.
Next Document:  Metastatic tumors in the hand from adenocarcinoma of the colon.